ESTRO 2024 - Abstract Book
S609
Clinical - Breast
ESTRO 2024
activation in terms of toxicities. In this regard, our analysis represents a starting point for future efficacy and safety real world evaluations of adjuvant radio-immunotherapy combination in patients with early triple negative breast cancer.
Keywords: Radioimmunotherapy, Feasibility
Made with FlippingBook - Online Brochure Maker